Clinical trial
Antiepileptic Drug Carbamazepine in Treatment of Bronchial Asthma
NCT00207428 · Centre of Chinese Medicine, Georgia, Other · Completed
Key facts
| NCT number | NCT00207428 |
|---|---|
| Title | Antiepileptic Drug Carbamazepine in Treatment of Bronchial Asthma |
| Official title | Randomized, Placebo Controlled, Double Blind Study of Carbamazepine in Treatment of Bronchial Asthma |
| Lead sponsor | Centre of Chinese Medicine, Georgia, Other |
| Collaborators | Rea Rehabilitation Centre, Georgia |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bronchial Asthma |
| Intervention type | Drug |
| Interventions | Carbamazepine |
| Enrollment | 65 |
| Start date | Aug 1, 1999 |
| Completion | Apr 1, 2000 |
| First posted | Sep 21, 2005 |
| Last update posted | May 16, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: